Shopping Cart 0
Cart Subtotal
USD 0

Purdue University - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Purdue University (Purdue) is an academic and research institution that offers undergraduate, post graduate, honors and research programs. The institution provides off-campus academic programs such as distance learning, zip trips, youth programs and opportunities to study abroad. It offers undergraduate courses in the fields of accounting, agriculture, education, engineering, animation, anthropology, health sciences, liberal arts, polytechnic, exploratory studies and management, among others. Purdue conducts research in the areas of information technology, manufacturing, healthcare, life sciences, information technology, hospitality and financial services, among others. The university works in partnership with various research centers, institutes and companies. Purdue is headquartered in West Lafayette, Indiana, the US.

Purdue University-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Purdue University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Purdue University, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Purdue University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Purdue University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Purdue University, Medical Devices Deals, 2012 to YTD 2018 9

Purdue University, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Purdue University, Pharmaceuticals & Healthcare, Deal Details 11

Asset Purchase 11

Purdue University Acquires LAESI DP-1000 Instrument System from Protea Biosciences 11

Venture Financing 12

Symic Biomedical Raises USD15 Million in Series A Financing 12

Partnerships 13

Eli Lilly and Purdue University Enter into Research Agreement 13

Purdue University Enters into MoU with Dr Reddy's Labs 14

Licensing Agreements 15

Cantabio Pharma Enters into Licensing Agreement with Purdue Research Foundation 15

Akanocure Pharma Enters into Licensing Agreement with Purdue Research Foundation 16

Neuro Vigor Enters into Licensing Agreement with Purdue Research Foundation 17

Linus Oncology Enters into Licensing Agreement with Purdue University 18

Aldrich Chemical Enters Into Licensing Agreement With Purdue Research Foundation And Purdue Office of Technology Commercialization 19

Purdue University-Key Competitors 20

Purdue University-Key Employees 21

Purdue University-Locations And Subsidiaries 22

Head Office 22

Other Locations & Subsidiaries 22

Recent Developments 24

Government and Public Interest 24

Sep 18, 2018: USD 1.7 million SBIR grant fast-tracks faster bone fracture healing 24

Aug 21, 2018: New type 1 diabetes therapy shows promise for long-term reversal in both humans, dogs 26

Jun 15, 2018: New compound shown to be as effective as FDA-approved drugs against life-threatening infections; tests indicate it is less susceptible to resistance 28

Apr 12, 2018: Microscopic oxygen bubbles could help improve cancer therapeutics and accelerate wound healing 29

Aug 10, 2017: TSRL Awarded Two NIH Grants to Develop Therapeutics for Multi-Drug Resistant Infections 30

Mar 28, 2017: An old drug with new potential: WWII chemical-weapon antidote shows early promise as treatment for spinal cord injuries 31

Product News 32

Aug 01, 2018: Purdue researchers develop tornado lab-on-a-chip technology with micro tweezers to detect dangerous viruses, biological contaminants 32

Feb 20, 2018: Purdue targeted drug combination could expedite bone fracture healing, be used as injection 33

Other Significant Developments 35

Jul 24, 2018: New 3D, curved technology provides hope for patients and doctors battling some of the most devastating types of cancer 35

Jun 08, 2018: Gene editing just got easier 36

Appendix 38

Methodology 38

About GlobalData 38

Contact Us 38

Disclaimer 38


List Of Figure

List of Figures

Purdue University, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Purdue University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Purdue University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Purdue University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Purdue University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Purdue University, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Purdue University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Purdue University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Purdue University, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

Purdue University, Pharmaceuticals & Healthcare, Key Facts 2

Purdue University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Purdue University, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Purdue University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Purdue University, Deals By Therapy Area, 2012 to YTD 2018 8

Purdue University, Medical Devices Deals, 2012 to YTD 2018 9

Purdue University, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Purdue University Acquires LAESI DP-1000 Instrument System from Protea Biosciences 11

Symic Biomedical Raises USD15 Million in Series A Financing 12

Eli Lilly and Purdue University Enter into Research Agreement 13

Purdue University Enters into MoU with Dr Reddy's Labs 14

Cantabio Pharma Enters into Licensing Agreement with Purdue Research Foundation 15

Akanocure Pharma Enters into Licensing Agreement with Purdue Research Foundation 16

Neuro Vigor Enters into Licensing Agreement with Purdue Research Foundation 17

Linus Oncology Enters into Licensing Agreement with Purdue University 18

Aldrich Chemical Enters Into Licensing Agreement With Purdue Research Foundation And Purdue Office of Technology Commercialization 19

Purdue University, Key Competitors 20

Purdue University, Key Employees 21

Purdue University, Other Locations 22

Purdue University, Subsidiaries 22

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Purdue University, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.